相关实验视频

Updated: Jan 7, 2026

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

研究合成和结构-活性关系的3-基黄具有多种氧化D环分子

Arisa Tsutsumi¹, Satoru Kawaii², Yuko Yoshizawa³

¹Laboratory of Bio-organic Chemistry, Tokyo Denki University, Hatoyama, Japan.

Anticancer research

|December 30, 2025

概括

将基组引入-3-styrylflavones显著增强了它们的抗增殖活性. D环部分的氨酸结构至关重要,这表明这些化合物可能充当线粒体.

科学领域:

药用化学医学化学
有机合成有机合成
药理学药理学是指药理学的学科.

背景情况:

黄是一种黄类的亚类,是常见的饮食化合物,具有潜在的药用应用.
之前的聚甲基化3- styrylflavones的合成显示了有限的抗增殖作用.
对D环部分的基组进行了研究,以确定它们对抗增殖活性的影响.

研究的目的:

为了合成新型的3 - styrylflavones与基化D环部分.
为了评估这些合成化合物的抗增殖活性.
了解有关基组放置的结构-活性关系.

主要方法:

通过维蒂格反应系统合成3- styrylflavones.
使用的氧化甲衍生物和3-甲基) 黄衍生物.
评估了对HL60癌细胞系的抗增殖活性.

主要成果:

两个化合物,2′′′,5′′′-二基-2',3',4′-三基-3- styrylflavone和2′′′,5′′′-二基-3',4',5′-三基-3-styrylflavone显示出显著的活性.
对于最强大的化合物,记录了16μM的IC50值.
D环的氧化显著改善了抗增殖效应.

结论:

在3-styryl替代剂中引入基组是增强抗增殖活性的关键.
在D环中的氨酸结构对于活性至关重要.
这些带有基类型D环的3 - styrylflavones可能作为线粒体起作用.

关键词:

在HL60细胞中.氧化3-烯黄的三化.维蒂格的反应反应.它们具有抗增殖活动的抗增殖活性.styryl-flavone 杂交分子分子中的一个.

更多相关视频

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Synthesis of pH Dependent Pyrazole, Imidazole, and Isoindolone Dipyrrinone Fluorophores using a Claisen-Schmidt Condensation Approach

Synthesis of pH Dependent Pyrazole, Imidazole, and Isoindolone Dipyrrinone Fluorophores using a Claisen-Schmidt Condensation Approach

Published on: June 10, 2021

相关概念视频

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...

Stereoisomerism of Cyclic Compounds

Stereoisomerism of Cyclic Compounds

In this lesson, we delve into the role of ring conformation and its stability, which determines the spatial arrangement and, consequently, the molecular symmetry and stereoisomerism of cyclic compounds. 1,2-Dimethylcyclohexane is used as a case study to evaluate the possible number of stereoisomers. Here, given the multiple (n = 2) chiral centers, there are 2n = 4 possible configurations that lack a plane of symmetry, as the ring skeleton exists in a non-planar chair conformation. In addition,...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...